Marksans Pharma

quarterly
yearly
ParticularsSep '24Dec '24Mar '25Jun '25Sep '25
Revenue641.85709.70723.80625.63741.98
Expenses517.25566.44607.71549.04608.65
EBITDA146.74166.62142.27105.76166.07
EBIT127.23145.93119.5382.67139.15
Profit Before Tax124.60143.26116.1076.60133.34
Net Profit97.76105.0790.7358.2099.14
Financial Ratios
Operating Profit Margin22.86%24.43%20.08%17.06%23.05%
Net Profit Margin15.07%15.33%12.78%9.41%13.64%
Earning Per Share (Diluted)2.132.312.001.292.17
Dividends Per Share0.000.000.000.000.00